, From the analyst's couch: Value of novelty?, Nature Reviews Drug Discovery, vol.1, issue.8, pp.571-572, 2002.
DOI : 10.1038/nrd884
, Teaching old receptors new tricks: biasing seven-transmembrane receptors, Nature Reviews Drug Discovery, vol.28, issue.5, pp.373-386, 2010.
DOI : 10.1038/nrd3024
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2902265
, Ligand-selective receptor conformations revisited: the promise and the problem, Trends in Pharmacological Sciences, vol.24, issue.7, pp.346-354, 2003.
DOI : 10.1016/S0165-6147(03)00167-6
, A unique mechanism of beta-blocker action: Carvedilol stimulates beta-arrestin signaling, Proceedings of the National Academy of Sciences, vol.104, issue.42, pp.16657-16662, 2007.
DOI : 10.1073/pnas.0707936104
, Agonist-receptor efficacy II: agonist trafficking of receptor signals, Trends in Pharmacological Sciences, vol.16, issue.7, pp.232-238, 1995.
DOI : 10.1016/S0165-6147(00)89032-X
, Functional Selectivity and Classical Concepts of Quantitative Pharmacology, Journal of Pharmacology and Experimental Therapeutics, vol.320, issue.1, pp.1-13, 2007.
DOI : 10.1124/jpet.106.104463
, Sequential Binding of Agonists to the ??2 Adrenoceptor: KINETIC EVIDENCE FOR INTERMEDIATE CONFORMATIONAL STATES, Journal of Biological Chemistry, vol.279, issue.1, pp.686-691, 2004.
DOI : 10.1074/jbc.M310888200
, Fluorescence Resonance Energy Transfer Analysis of ??2a-Adrenergic Receptor Activation Reveals Distinct Agonist-Specific Conformational Changes, Molecular Pharmacology, vol.75, issue.3, pp.534-541, 2009.
DOI : 10.1124/mol.108.052399
, G protein coupled receptor structure and activation, Biochimica et Biophysica Acta (BBA) - Biomembranes, vol.1768, issue.4, pp.794-807, 2007.
DOI : 10.1016/j.bbamem.2006.10.021
, Conformational changes in G-protein-coupled receptors-the quest for functionally selective conformations is open, British Journal of Pharmacology, vol.274, issue.S1, pp.358-366, 2008.
DOI : 10.1038/sj.bjp.0707615
, Conformational complexity of G-protein-coupled receptors, Trends in Pharmacological Sciences, vol.28, issue.8, pp.397-406, 2007.
DOI : 10.1016/j.tips.2007.06.003
, ??-Arrestin-mediated activation of MAPK by inverse agonists reveals distinct active conformations for G protein-coupled receptors, Proceedings of the National Academy of Sciences, vol.100, issue.20, pp.11406-11411, 2003.
DOI : 10.1073/pnas.1936664100
, Functional Selectivity through Protean and Biased Agonism: Who Steers the Ship?, Molecular Pharmacology, vol.72, issue.6, pp.1393-1401, 2007.
DOI : 10.1124/mol.107.040352
, Atomic scale movement of the voltagesensing region in a potassium channel measured via spectroscopy, Nature, vol.402, issue.6763, pp.809-813, 1999.
, Molecular Basis of V2 Vasopressin Receptor/GsCoupling Selectivity, Journal of Biological Chemistry, vol.273, issue.41, pp.26549-26558, 1998.
DOI : 10.1074/jbc.273.41.26549
, Beta-adrenergic receptor kinase: identification of a novel protein kinase that phosphorylates the agonist-occupied form of the receptor., Proceedings of the National Academy of Sciences, vol.83, issue.9, pp.2797-2801, 1986.
DOI : 10.1073/pnas.83.9.2797
, Peptide and non-peptide agonists and antagonists for the vasopressin and oxytocin V1a, V1b, V2 and OT receptors: research tools and potential therapeutic agents???, Prog Brain Res, vol.170, pp.473-512, 2008.
DOI : 10.1016/S0079-6123(08)00437-8
, Biased Agonist Pharmacochaperones of the AVP V2 Receptor May Treat Congenital Nephrogenic Diabetes Insipidus, Journal of the American Society of Nephrology, vol.20, issue.10, pp.2190-2203, 2009.
DOI : 10.1681/ASN.2008121289
URL : https://hal.archives-ouvertes.fr/inserm-00421838
, Trapping and Stabilization of Integral Membrane Proteins by Hydrophobically Grafted Glucose-Based Telomers, Biomacromolecules, vol.10, issue.12, pp.3317-3326, 2009.
DOI : 10.1021/bm900938w
, Amphipols, Nanodiscs, and Fluorinated Surfactants: Three Nonconventional Approaches to Studying Membrane Proteins in Aqueous Solutions, Annual Review of Biochemistry, vol.79, issue.1, pp.737-775, 2010.
DOI : 10.1146/annurev.biochem.052208.114057
, vasopressin receptor induces a constitutive activity which permits discrimination between antagonists with partial agonist and inverse agonist activities, FEBS Letters, vol.272, issue.3, pp.470-475, 1998.
DOI : 10.1016/S0014-5793(98)01585-3
, Association of ??-Arrestin with G Protein-coupled Receptors during Clathrin-mediated Endocytosis Dictates the Profile of Receptor Resensitization, Journal of Biological Chemistry, vol.274, issue.45, pp.32248-32257, 1999.
DOI : 10.1074/jbc.274.45.32248
, Dynamics of Arrestin-Rhodopsin Interactions: ARRESTIN AND RETINAL RELEASE ARE DIRECTLY LINKED EVENTS, Journal of Biological Chemistry, vol.280, issue.8, pp.6861-6871, 2005.
DOI : 10.1074/jbc.M411341200
, Structure and Conformational Changes in the C-terminal Domain of the beta2-Adrenoceptor: INSIGHTS FROM FLUORESCENCE RESONANCE ENERGY TRANSFER STUDIES, Journal of Biological Chemistry, vol.282, issue.18, pp.13895-13905, 2007.
DOI : 10.1074/jbc.M611904200
, Effects of the luteinising hormone-releasing hormone (LH-RH) agonist leuprolide on adenylyl cyclase regulation through G-protein coupled receptors in rat ventral prostate, European Journal of Cancer, vol.37, issue.5, pp.641-648, 2001.
DOI : 10.1016/S0959-8049(00)00443-3
, Conformational changes: How small is big enough?, Nature Medicine, vol.35, issue.10, pp.1112-1114, 1998.
DOI : 10.1038/370389a0
, Structure of a nanobody-stabilized active state of the ??2 adrenoceptor, Nature, vol.104, issue.7329, pp.175-180, 2011.
DOI : 10.1038/nature09648
, Crystal structure of the ??2 adrenergic receptor???Gs protein complex, Nature, vol.61, issue.7366, pp.549-555, 2011.
DOI : 10.1038/nature10361
, Crystal structure of metarhodopsin II, Nature, vol.104, issue.7340, pp.651-655, 2011.
DOI : 10.1038/nature09789